Oligometastatic Disease Detection with (68)Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer Patients (HSPC) with Biochemical Recurrence after Radical Prostatectomy: Predictive Factors and Clinical Impact

SIMPLE SUMMARY: The early treatment of oligometastatic disease (OMD) is a promising therapeutic option for prostate cancer as it has the potential of delaying androgen-deprivation therapy (ADT) and disease progression. Next-generation imaging targeting the prostate-specific membrane antigen (PSMA-PE...

Descripción completa

Detalles Bibliográficos
Autores principales: Artigas, Carlos, Diamand, Romain, Shagera, Qaid Ahmed, Plouznikoff, Nicolas, Fokoue, Fabrice, Otte, François-Xavier, Gil, Thierry, Peltier, Alexandre, Van Gestel, Dirk, Flamen, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508549/
https://www.ncbi.nlm.nih.gov/pubmed/34638466
http://dx.doi.org/10.3390/cancers13194982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508549/
https://www.ncbi.nlm.nih.gov/pubmed/34638466
http://dx.doi.org/10.3390/cancers13194982

Ejemplares similares